Performing cell-to-cell interaction and ligand-receptor analyses on spatial transcriptomics data they identified TIGIT expression on T and NK cells correlating with the expression of its ligands PVR and PVRL2 on myeloid and tumor cells. The gene discussed is TIGIT; the disease is neoplasm.